SPRY

#2141

ARS Pharmaceuticals, Inc. Common Stock

9.2970

-1.62%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

-1.62%

Месячное изменение

-11.46%

6-месячное изменение

+0.94%

Годовое изменение

+0.94%

Предыдущее закрытие

9.4500

Open

9.2800

Bid

Ask

Low

9.2800

High

9.2970

Объем

101

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 66.76 M40.08 M59.27 M13.55 M 112.47 M Cash from investing activities 66.48 M199 K87.18 M106.1 M 134.41 M Cash from financing activities 614 K190.73 M6.9 M72.4 M 174.38 M Free cash flow 65.39 M39.88 M59.09 M12.98 M 111.83 M

SPRY

Financials

Новости

ARS Pharmaceuticals Stock: Climbing Neffy Sales Global Expansion Re-Rate (NASDAQ:SPRY)

What's Going On With ARS Pharmaceuticals Stock Friday? - ARS Pharmaceuticals (NASDAQ:SPRY)

Why Is Aquestive Therapeutics Stock Falling Today? - Aquestive Therapeutics (NASDAQ:AQST)

China approves first community use epinephrine nasal spray for allergies

ARS Pharma CBO Chakma sells shares worth $1.47 million

Dorsey, ARS Pharma COO, sells $190k in SPRY stock

ARS Pharmaceuticals, Inc. (SPRY) Q3 2025 Earnings Call Transcript

ARS Pharmaceuticals stock reaffirmed Outperform by William Blair on neffy data

ARS Pharmaceuticals stock rises on strong Q3 sales, Raymond James reiterates Strong Buy

ARS Pharmaceuticals, Inc. (SPRY) Reports Q3 Loss, Beats Revenue Estimates

ARS Pharmaceuticals earnings missed by $0.06, revenue topped estimates

Lipocine (LPCN) Reports Q3 Loss, Tops Revenue Estimates